Tests smell and taste in people with ALS and their nutrition
Studies whether smell and taste affect nutrition in adults with amyotrophic lateral sclerosis.
Key facts
- Who runs it
- Centre Hospitalier Universitaire Dijon
- Where
- Dijon, FranceSee the site
- Trial code
- Registry title
- Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 12 May 2026
- Expected to end
- 12 May 2029
- Type of study
- Observational
- Treatments tested
- test taking
- Record updated
- 15 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed definite or probable ALS, followed at a participating regional centre, who speak French.
- Age
- Over 18 years
- Sex
- Men and women
- Disease stage
- Newly diagnosed (incident) definite or probable ALS according to El-Escorial criteria
- Earlier treatment
- No antibiotic treatment for an acute infection at the time of inclusion
Main reasons for not taking part
- Severe bulbar problems from the start that prevent swallowing, or eating only through a gastrostomy
- Severe diaphragm weakness needing non-invasive ventilation from the start
- Known food allergy
- 10 or more standard drinks of alcohol per week, or stopped smoking less than 1 month ago
- Psychiatric, cognitive or neurological disorders that make it impossible to assess food preferences
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Incident cases of definite or probable ALS according to El-Escorial criteria (3) followed up at the participating regional centre of competence
- Patient aged over 18
- Patient fluent in French
- Patient having given oral consent
Who cannot take part
- Patients with an acute infection undergoing antibiotic treatment at the time of inclusion
- Patients with psychiatric, cognitive or neurological disorders making it impossible to assess food preferences
- Patient with a known food allergy
- Patient with severe diaphragmatic impairment requiring NIV from the outset
- Patients with excessive alcohol consumption (≥ 10 standard drinks per week)
- Patients who have stopped smoking for less than 1 month
- Patients with severe bulbar involvement from the outset, preventing swallowing, patients with aphagia or patients eating exclusively via a gastrostomy
- Person not affiliated to or not benefiting from a social security scheme
- Person under legal protection (curatorship, guardianship)
- Persons subject to a legal protection measure
- Pregnant women, women in labour or breastfeeding mothers
- An adult who is incapable or unable to give consent
- Minors
Where in France
- Chu Dijon BourgogneDijon, FranceContact: Marjolaine GEORGESTaking people
About the trial
What the trial wants to find out
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by progressive diffuse muscular paralysis due to the inexorable loss of motor neurons in the primary motor cortex, the corticospinal tract, the brain stem and the spinal cord.
Read full original descriptionShow less
Over the course of the disease, when the phrenic motor neurons are involved, diaphragmatic weakness develops, leading to restrictive respiratory failure, which is the main cause of morbidity and mortality. Non-invasive ventilation (NIV) compensates for diaphragm failure and corrects the associated symptoms, and has been shown to prolong patient survival and improve quality of life.
Undernutrition is another recognised prognostic factor. Several mechanisms have been described, foremost of which are a state of hypermetabolism and a reduction in food intake secondary to chewing difficulties, dysphagia, a loss of dexterity in the upper limbs, a disturbance in salivary secretion or psychological disorders. In addition, diaphragmatic dysfunction plays a direct role in the onset of undernutrition, as compensatory contraction of the accessory neck muscles increases resting energy expenditure.
However, the hedonic sensations triggered by a meal play a role in controlling food intake beyond the simple energy balance between calorie intake and energy expenditure. Olfacto-gustatory sensoriality could therefore play a role in the nutritional status of patients suffering from ALS.
Diaphragmatic dysfunction may also influence nutritional status by other mechanisms. For example, the reduction in inspiratory capacity associated with diaphragmatic insufficiency reduces olfaction in a group of tetraplegic patients. Central sensory impairment could exacerbate this phenomenon. Although it is conventionally considered that there are no sensory manifestations during the course of ALS, minor but diffuse abnormalities of the nerves and sensory action potentials have been observed. A central alteration in olfacto-gustatory sensoriality could be part of the neurological manifestations of ALS. In addition, olfactory deficits occur in other neuromuscular diseases with central involvement, such as myasthenia, Parkinson\'s or Alzheimer\'s disease, in the absence of concomitant cognitive or diaphragmatic impairment.
Our hypothesis is that impaired olfacto-gustatory function favours the onset of undernutrition in ALS.
Current nutritional management consists of ensuring adequate calorie intake by prescribing oral food supplements or inserting a gastrostomy. Taking personalised account of food preferences during dietary advice or of a potential olfacto-gustatory deficit, by reinforcing smells or tastes during food consumption, would be an interesting additional therapeutic avenue for improving patients\' nutritional status, quality of life and prognosis
The group in the trial
- patient
ALS patients referred to the ALS Reference Centre at Dijon University Hospital and Lyon University Hospital
Treatment: test taking
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
- Plain-language title
- Tests smell and taste in people with ALS and their nutritionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 May 2026